Buonamici, S., Yoshimi, A., Thomas, M., Seiler, M., Chan, B., Csibi, A., Fekkes, P., Klimek, V., Kumar, P., Lee, S., Padron, E., Pazolli, E., Goldberg, J., Sahmoud, T., Taylor, J., Warmuth, M., Yu, L., Zhu, P., Abdel-Wahab, O., & Smith, P. (n.d.). characterization of Novel Oral Splicing Modulator, H3B-8800, Identifies the Mechanistic Basis for its Preferential Lethality Towards Spliceosome-Mutant Myeloid Malignancy Models. Leukemia research, 55, S11–. http://access.bl.uk/ark:/81055/vdc_100045920464.0x000049